United Kingdom

The information displayed in this site is for products marketed in UK. Please select a product from the following list.

  • Synalar Gel

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar Ointment 0.025% W/W

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar Ointment 1 in 4 Dilution

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar C Cream

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar C Ointment

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar Cream

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar Cream 1 in 10 Dilution

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar Cream 1 in 4 Dilution

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar N Cream

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Synalar N Ointment

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Metosyn FAPG Cream

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Metosyn Ointment

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Micanol Cream 1%

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Micanol Cream 3%

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Crystacide Cream 1%

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 44095 from the list for product information of our laboratory.
    See MHRA website.

  • Cefotaxime 1g Powder for Solution for Injection or Infusion

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 25174 from the list for product information of our laboratory.
    See MHRA website.

  • Cefotaxime 2g Powder for Solution for Injection or Infusion

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 25174 from the list for product information of our laboratory.
    See MHRA website.

  • Pantoprazol 40mg powder for solution for injection

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 25174 from the list for product information of our laboratory.
    See MHRA website.

  • Ceftriaxone 1g Powder for Solution for Injection or Infusion

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 25174 from the list for product information of our laboratory.
    See MHRA website.

  • Ceftriaxone 2g Powder for Solution for Injection or Infusion

    Product information

    Please click here

    Medical enquiries

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report a production issue

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Report an adverse event

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to send your enquiry.

    Commercial

    Please This email address is being protected from spambots. You need JavaScript enabled to view it. to contact the commercial department.
    You will be redirected to the MHRA (Medicines & Healthcare products Regulatory Agency) site information regarding product information on SPCs (Summary of Product Characteristics) for healthcare professionals or PILs (Patient Information Leaflets). Please read the information displayed and tick the box at the bottom of the page to proceed to view the product information in pdf format. You must select PL 25174 from the list for product information of our laboratory.
    See MHRA website.

This site uses only technical third party cookies to provide better service, when browsing this website you agree to its use. See ourlegal advice. Agree

Our website is protected by DMC Firewall!